Physician profile
Wendy Bernstein
NPI 1679516066
$16,107.28
in general payments reported to CMS, 2019-2025
8 companies · $1,612 in 2025
The $1,612 reported for 2025 was more than what 96% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $14K · 2024: $600 · 2025: $1,612.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Honoraria: $900 · Consulting Fee: $790 · Food and Beverage: $522.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Honoraria | $900.00 |
| Consulting Fee | $790.00 |
| Food and Beverage | $522.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $13,894.92 | 2020 | |
| Becton, Dickinson and Company | $1,641.82 | 2024-2025 | Hemosphere |
| Medtronic, INC. | $292.20 | 2025 | Bis, Invos, Plasmablade(Tm) |
| Ge Healthcare | $190.00 | 2025 | |
| Teleflex LLC | $33.00 | 2025 | Arrow |
| Baxter Healthcare | $19.79 | 2025 | Fluid Systems - Drug Delivery Systems |
| Fisher & Paykel Healthcare INC | $18.55 | 2025 | Fisher & Paykel Healthcare |
| La Jolla Pharmaceutical Company | $17.00 | 2025 | Giapreza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendy Bernstein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.